Biodexa Pharmaceuticals (BDRX) Assets (2013 - 2026)
Biodexa Pharmaceuticals' Assets came in at $17.07 million for the quarter ended Jun 30, 2026, down 13.7% from $19.78 million a year earlier.
Powered by 
Analysis
Biodexa Pharmaceuticals (BDRX) Assets (2013 - 2026) Analysis & Trends
As of Dec 31, 2025, Biodexa Pharmaceuticals' Assets was $23.97 million, up 26.9% from the prior year.
- Assets has increased in each of the last three years, with a five-year compound annual growth rate of 13.7% (years ended Dec 2020 to Dec 2025).
- Going back by year, Assets was $18.89 million in the year ended Dec 31, 2024 (+44.1%), $13.11 million in the year ended Dec 31, 2023 (+91.8%), $6.84 million in the year ended Dec 31, 2022 (-61.5%) and $17.77 million in the year ended Dec 31, 2021 (+40.9%).
- The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly Assets since the quarter ended Dec 31, 2023.
- Year-over-year, Assets increased in three of the last four quarters, with growth averaging 17.7%.
- The fastest year-over-year change in Assets over five years came in the quarter ended Dec 31, 2023 (growth of 101.9%), and the weakest in the quarter ended Dec 31, 2022 (a decline of 62.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Biodexa Pharmaceuticals | 41.06 Mn | 17.85 Mn | - | 17.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.07 Mn |
| Dec 31, 2025 | 24.18 Mn |
| Jun 30, 2025 | 19.78 Mn |
| Dec 31, 2024 | 18.97 Mn |
| Jun 30, 2024 | 17.63 Mn |
| Dec 31, 2023 | 13.08 Mn |
| Jun 30, 2023 | 9.96 Mn |
| Dec 31, 2022 | 6.48 Mn |
| Jun 30, 2022 | 12.19 Mn |
| Dec 31, 2021 | 17.41 Mn |
| Jun 30, 2021 | 11.57 Mn |
| Dec 31, 2020 | 12.96 Mn |
| Jun 30, 2020 | 14.90 Mn |
| Dec 31, 2019 | 39.72 Mn |
| Jun 30, 2019 | 36.70 Mn |
| Dec 31, 2018 | 26.31 Mn |
| Jun 30, 2018 | 48.84 Mn |
| Dec 31, 2017 | 65.35 Mn |
| Jun 30, 2017 | 57.86 Mn |
| Dec 31, 2016 | 70.48 Mn |
API Access
Biodexa Pharmaceuticals Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=BDRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "BDRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=BDRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();